Page 4 - Multiple Voting Share News Today

PsyBio Completes Reverse Take-Over Transaction Common Shares Expected to Commence Trading on the TSX Venture Exchange Imminently February 19, 2021 15:17 ET | Source: PsyBio Therapeutics Corp. PsyBio Therapeutics Corp. Not for distribution to United States newswire services or for release publication,  distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. TORONTO, Feb. 19, 2021 (GLOBE NEWSWIRE) -- PsyBio ...

   * Assumes a Consolidation ratio for the Common Shares of 1.6667:1 In the event that the Qualifying Transaction is completed, the directors of the Company who are not directors of the Resulting Issuer will have a period of 12 months to exercise their Options. In addition, the Company will also apply to the TSXV to extend the expiry date of the option grants expiring on February 17, 2021 to March 5, 2023. The Options are expected to represent less than 1% of the issued and outstanding shares...

KWG Resources Inc.: KWG Announces Proposed Private Placement of Flow-Through Units KWG Resources Inc. (CSE: KWG) (CSE: KWG.A) (FSE: KW6) ("KWG" or the "Company") is pleased to announce a proposed non-brokered private placement of up to 280,000 flow-through units (each a " Flow-Thorough Unit") at a price of $1.5001 per Flow-Through Unit for aggregate gross proceeds of up to $420,028 (the " Offering"). Each Flow-Through Unit is comprised of one multiple voting share of the Company (each, a " Mu...

(1) Chicago, Illinois--(Newsfile Corp. - December 18, 2020) - RCP23, LLC (the "Seller"), a private investment holding company controlled by Benjamin Kovler, CEO and Chairman of Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) (the "Issuer"), sold 2,500,000 Subordinate Voting Shares of the Issuer (the "Transferred Shares") to a third-party qualified institutional buyer at a purchase price of C$27.50 per share in a private transaction. Following the sale, Mr. Kovler, together with his join...